Last updated: 2 June 2020 at 5:15pm EST

Harold J Wiens Net Worth




The estimated Net Worth of Harold J Wiens is at least $649 mil dollars as of 22 May 2020. Harold Wiens owns over 3,985 units of Bio-Techne Corp stock worth over $648,770 and over the last 11 years Harold sold TECH stock worth over $0.

Harold Wiens TECH stock SEC Form 4 insiders trading

Harold has made over 4 trades of the Bio-Techne Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently Harold exercised 3,985 units of TECH stock worth $403,242 on 22 May 2020.

The largest trade Harold's ever made was exercising 4,260 units of Bio-Techne Corp stock on 6 May 2020 worth over $372,068. On average, Harold trades about 1,187 units every 14 days since 2014. As of 22 May 2020 Harold still owns at least 8,828 units of Bio-Techne Corp stock.

You can see the complete history of Harold Wiens stock trades at the bottom of the page.



What's Harold Wiens's mailing address?

Harold's mailing address filed with the SEC is 614, Northeast McKinley Place, Minneapolis, Hennepin County, Minnesota, 55413, United States.

Insiders trading at Bio-Techne Corp

Over the last 22 years, insiders at Bio-Techne Corp have traded over $37,160,097 worth of Bio-Techne Corp stock and bought 4,361 units worth $454,370 . The most active insiders traders include Charles R. Kummeth, Rupert Vessey, eJohn L Higgins. On average, Bio-Techne Corp executives and independent directors trade stock every 23 days with the average trade being worth of $964,850. The most recent stock trade was executed by Kim Kelderman on 29 August 2024, trading 1,492 units of TECH stock currently worth $99,919.



What does Bio-Techne Corp do?

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.



Complete history of Harold Wiens stock trades at Bio-Techne Corp

Acionista maioritário
Trans.
Transação
Preço total
Harold J Wiens
Exercício de opção $403,242
22 May 2020
Harold J Wiens
Exercício de opção $372,068
6 May 2020
Harold J Wiens
Exercício de opção $367,120
30 Apr 2020
Harold J Wiens
Exercício de opção $175,660
4 Dec 2019


Bio-Techne Corp executives and stock owners

Bio-Techne Corp executives and other stock owners filed with the SEC include: